Results 301 to 310 of about 273,619 (385)

Momelotinib Is Effective in Treatment for VEXAS Syndrome: Two Cases Within the AGMT Austrian Myeloid Registry

open access: yesEuropean Journal of Haematology, Volume 115, Issue 3, Page 299-302, September 2025.
ABSTRACT VEXAS syndrome is caused by somatic mutations in the UBA1 gene and includes features of both autoinflammatory and myeloid diseases. Among several treatment options, JAK inhibitors have proven effective, especially ruxolitinib. However, anemia is often present in VEXAS syndrome.
Dominik Kiem   +7 more
wiley   +1 more source

Cutaneous vasculitis and IgA glomerulonephritis in ankylosing spondylitis.

open access: bronze, 1993
Catherine Beauvais   +4 more
openalex   +1 more source

Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2017
Hui Zhang   +7 more
semanticscholar   +1 more source

Child With Painful Purpuric Rash of the Hands and Feet

open access: yes
Pediatric Dermatology, EarlyView.
Andrew J. Gauger   +3 more
wiley   +1 more source

American College of Rheumatology Guidance Statements for Addressing Mental Health Concerns in Youth With Pediatric Rheumatologic Diseases

open access: yesArthritis Care &Research, Volume 77, Issue 8, Page 953-964, August 2025.
Objective Pediatric rheumatologic diseases (PRDs) are characterized by high rates of anxiety and depression known to impact health‐related outcomes. We present guidance statements to assess and manage mental health concerns for youth with PRDs in pediatric rheumatology practice.
Natoshia R. Cunningham   +21 more
wiley   +1 more source

Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2017
A. Schreiber   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy